معرفی
Dr. Stephen Mullin is an Associate Professor and Honorary Consultant in Neurology at Peninsula Medical School. His work bridges clinical practice and academic research, focusing on Parkinson's disease, genetic risk factors, and machine learning applications in healthcare.
His research emphasizes the genetic and clinical stratification of Parkinson's disease, particularly through the glucocerebrosidase (GBA) pathway. He leads initiatives like the Rapsodi cohort study for GBA mutation risk assessment and Pdfrontline, a genotyping portal for Parkinson's patients. His expertise extends to clinical trial design, including a phase II trial of ambroxol as a neuroprotective agent.
He actively contributes to external bodies, including chairing the infrastructure committee of the ACT-PD consortium, advising on the ROPAD study, and serving on the Royal College of Physicians' Neurology SCE exam committee. His recent publications highlight applications of AI and deep learning in MRI-based diagnostics for neurological and cardiovascular conditions, though no specific awards are listed.
